Advancing New Technologies for Brain Stimulation


brain stimulation device

Developing Innovative Digital Therapeutics Solutions

At OptoCeutics, we are committed to developing disease-modifying digital therapeutics (DTx) for neurodegenerative and psychological disorders such as Alzheimer’s, MCI, ADHD, and depression.

We work at the intersection of neuroscience, engineering and artificial intelligence to create preventive health solutions that are safe, non-invasive and drug-free.


Sign-up to our newsletter and receive new information about our developments, clinical trials and more.

mosaico 1 1

Investigating Gamma Brain Waves for Alzheimer’s Disease

OptoCeutics is currently conducting clinical studies to investigate the potential therapeutical effects of masked 40 Hz flickering light on Alzheimer’s disease patients.

DISCLAIMER: All devices used in trials are considered investigational devices and limited to investigational use only.

homepage collage 1024x1024 1

Selected Partners

Latest News

Press & Mentions

Read more about the team behind the project.

Where to Find Us